维普中文期刊产品整合服务
34篇 您的检索式:作者名="Omlin A"
    题名 作者 年代 出处 被引量
1The role ofpemetrexed in advanced non small-cell lung cancer:special focus on pharmacology and mechanism of action显示文摘Joerger M Omlin A Cerny T 2010Curr Drug Targets2010,11,1:1
2Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network显示文摘Omlin A Amichetti M Azria D 2006Lancet Oncol2006,7,8:1
3Therapeutic options for advanced prostatecancer: 2011 update显示文摘Omlin A de Bono JS 2012Curr Urol Rep2012,13,2:1
4Evolving classification systems for cancer cachexia: ready for clinical practice? 显示文摘Blum D Omlin A Fearon K 2010Support Care Cancer2010,18,3:1
5The role of pemetrexed in ad vanced non small cell lung cancer: special focus on pharmacology an mechanism of action显示文摘Joerger M Omlin A Cerny T 2010Curr Drug Targets2010,11,1:1
6The role of pemetrexed inadvanced non small-cell lung cancer: special focus on pharmacology and mechanism of action显示文摘Joerger M Omlin A Cemy T 2010Curr Drug Targets2010,11,1:1
7Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lung显示文摘Omlin A D 'addario G Gillessen S 2009Lung Cancer2009,65,3:1
8Evolving classification systems for cancercachexia: Ready for clinical practice- 显示文摘Blum D Omlin A Fearon K 2010Support Care Cancer2010,18,3:1
9Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy显示文摘Omlin A Pezaro C Gillessen SS 2014Ther Adv Urol2014,6,1:1
10The role of pemetrexed in advanced non small-cell lung cancer: special focus on pharmacology and mechanism of action 显示文摘Joerger M Omlin A Cemy T 2010Curr Drug Targets2010,11,1:1
11Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lung显示文摘Omlin A D'Addario G Gillessen S 2009Lung Cancer2009,65,3:1
12Psychological state estimation from physiological recordings during robot assisted gait rehabilitation 显示文摘KOENIG A OMLIN X ZIMMERLI L 2011Journal of Rehabilitation Research & Development2011,48,4:1
13Evolving classification systems for cancer caehexia: Ready for clinical practice? 显示文摘Blum D Omlin A Fearon K 2010Support Care Cancer2010,18,3:1
14Psychological state estimation from physiological recordings during robot - assisted gait rehabilita- tion 显示文摘Koenig A Omlin X Zimmerli L 2011J Rehabil Res Dev2011,48,4:1
15Poly (ADP-ribose) poly- merase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer显示文摘Sandhu SK Omlin A Hylands L 2013Ann Oncol2013,24,5:1
16Poly (ADP-ribose) polymerase(PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer显示文摘Sandhu S K Omlin A Hylands L 2013Ann Oncol2013,24,5:1
17The changing therapeutic land- scape of castration-resistant prostate cancer 显示文摘Yap TA Zivi A Omlin A 2011Nat Rev Clin On- col2011,8,10:1
18Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy显示文摘Omlin A Pezaro C Sommer S G 2014Ther Adv Urol2014,6,1:1
19Antitumour activity of abi- raterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer 显示文摘Omlin A J Pezaro C Zaidi S 2013Br J Cancer2013,3,:1
20Clinical variables as- sociated with PSA response to abiraterone acetate in patients with me- tastatic castration-resistant prostate cancer 显示文摘Leibowitz-Amit R Templeton A J Omlin A 2014Ann Oncol2014,25,65:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费